SpotLight Proteomics: uncovering the hidden blood proteome improves diagnostic power of proteomics

Abstract

The human blood proteome is frequently assessed by protein abundance profiling using a combination of liquid chromatography and tandem mass spectrometry (LC-MS/MS). In traditional sequence database search, many good-quality MS/MS data remain unassigned. Here we uncover the hidden part of the blood proteome via novel SpotLight approach. This method combines de novo MS/MS sequencing of enriched antibodies and co-extracted proteins with subsequent label-free quantification of new and known peptides in both enriched and unfractionated samples. In a pilot study on differentiating early stages of Alzheimer’s disease (AD) from Dementia with Lewy Bodies (DLB), on peptide level the hidden proteome contributed almost as much information to patient stratification as the apparent proteome. Intriguingly, many of the new peptide sequences are attributable to antibody variable regions, and are potentially indicative of disease etiology. When the hidden and apparent proteomes are combined, the accuracy of differentiating AD (n = 97) and DLB (n = 47) increased from ≈85% to ≈95%. The low added burden of SpotLight proteome analysis makes it attractive for use in clinical settings.

The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response

“…The robustness of the model was evaluated by the 7-fold cross-validation operation built-in in SIMCA 15. The goodness of fit (R 2 X) and the predictability (Q 2 ) of this unsupervised PCA model were 0.63 and 0.42, which was comparable with other PCA models in the literature (20,21). The coefficients for each of the proteins in the corresponding supervised PLS-DA model were listed in Supplementary Table S7.…”

Altered Fc galactosylation in IgG4is a potential serum marker for chronic lung disease

“…Serum (40 µL per sample) and BALF (500 µL per sample) of patients and controls were aliquoted in triplicate. Polyclonal IgGs were enriched using the Melon Gel IgG Spin Purification Kit (Thermo Fisher Scientific, Gothenburg, Sweden) [ 20 ]. For details, see the supplementary material .…”

“…Samples were treated similarly to what has previously been described [ 20 ]. For serum, 10 µg of IgG per sample and for BALF, total IgG content per sample <10 µg was digested.…”

IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases

“…ing of the anti-MDA and the anti-PC IgM samples have been described elsewhere 15,28 . Data processing was performed using Spotlight proteomics approach 29 .…”